AstraZeneca lupus drug produces positive results in trial
November 17, 2014 at 07:00 AM EST
LONDON, Nov 17 (Reuters) - An experimental lupus drug from AstraZeneca significantly improved the symptoms of lupus in a mid-stage clinical trial, boosting prospects for a medicine the company believes could become a major seller.